The global Biologics market was valued at 10478.55 Million USD in 2021 and will grow with a CAGR of 4.98% from 2021 to 2027, based on Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
By Market Verdors:
Eli Lilly & Company
F Hoffman La Roche
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologics Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Monoclonal Antibodies
1.4.4 Recombinant Proteins
1.5 Market by Application
1.5.1 Global Biologics Market Share by Application: 2022-2027
1.5.2 Infectious Diseases
1.5.5 Autoimmune Diseases
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Biologics Market
1.8.1 Global Biologics Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Biologics Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Biologics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biologics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biologics Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Biologics Sales Volume Market Share by Region (2016-2021)
3.2 Global Biologics Sales Revenue Market Share by Region (2016-2021)
3.3 North America Biologics Sales Volume
3.3.1 North America
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Similar Reports: Retinal Biologics Market, Global Outlook and Forecast 2022-2028